Daniel Lubelski is a fellowship-trained neurosurgeon with expertise in complex spine surgery and peripheral nerve surgery. He treats patients with spinal diseases and deformities, spine and nerve tumors, and brachial plexus injuries and other peripheral nerve injuries. Dr. Lubelski’s training in complex and robotic spine surgery, spinal oncology and peripheral nerve injuries allows him to comprehensively evaluate patients and develop custom treatment plans to address symptoms and improve patients’ quality of life. He prioritizes patient-centered care, effective communication and working in multidisciplinary collaboration to identify the best treatment. After obtaining his undergraduate degree at the City University of New York, Dr. Lubelski spent a year doing predoctoral research at the National Institutes of Health. He then obtained his medical degree from the Cleveland Clinic Lerner College of Medicine, and he performed stem cell tumor research as a Howard Hughes Medical Institute fellow. Dr. Lubelski went on to the Johns Hopkins University School of Medicine for a neurosurgery residency and an enfolded fellowship in peripheral nerve surgery. His postdoctoral training also included a fellowship in complex spine surgery and spinal oncology at Johns Hopkins, as well as a traveling fellowship with advanced training at the Memorial Sloan Kettering Cancer Center and MD Anderson Cancer Center. Dr. Lubelski is a prolific researcher who focuses on patient quality of life and on using big data to develop individualized prediction models to determine optimal treatments tailored to each person. He has authored more than 200 peer-reviewed papers and numerous textbook chapters, has lectured nationally and internationally, and serves as a reviewer for the top neurosurgical journals. Dr. Lubelski is rated as an Elite provider by MediFind in the treatment of Spinal Tumor. His top areas of expertise are Spinal Tumor, Chordoma, Spinal Stenosis, Spinal Fusion, and Laminectomy.

Mari Groves is a Johns Hopkins pediatric neurosurgeon who cares for children with brain and spinal cord tumors (benign and cancerous), skeletal dysplasia, and spinal deformities such as neuromuscular and early scoliosis. She also sees patients diagnosed with Chiari malformations, spasticity and epilepsy. She specializes in treating patients with all types of spina bifida, including myelomeningocele. As part of the Johns Hopkins Center for Fetal Therapy, she is an expert in prenatal closure techniques such as minimally invasive fetoscopic repair of myelomeningocele (when the spina bifida defect is repaired before birth). Offering a transitional practice model of care, she follows patients diagnosed with spina bifida from birth to adulthood. Dr. Groves chose to pursue neurosurgery because it allows her to treat patients with complex conditions and help improve the quality of children’s lives. Her research interests focus on pediatric spinal disease and how surgical intervention can impact growth and neurological function during a child’s life. She is committed to building programs that support patients with congenital disorders as they age. Pediatric patients often age out of existing programs and have difficulty locating physicians and treating teams that understand their conditions. At Johns Hopkins, we have a unique ability to provide this type of comprehensive care. Dr. Groves earned her medical degree from the Vanderbilt University School of Medicine in 2007. She completed residency training in 2014 at The Johns Hopkins Hospital, where she remained for a neurosurgery fellowship, which she finished in 2015. She also completed a spinal deformity fellowship at Shriners Hospitals for Children in Philadelphia. Dr. Groves is rated as an Elite provider by MediFind in the treatment of Spinal Tumor. Her top areas of expertise are Spinal Tumor, Myelomeningocele, Tethered Cord Syndrome, Osteotomy, and Laminectomy.

Nicholas Theodore is a Neurosurgery provider in Baltimore, Maryland. Dr. Theodore is rated as a Distinguished provider by MediFind in the treatment of Spinal Tumor. His top areas of expertise are Tethered Cord Syndrome, Spinal Tumor, Spinal Stenosis, Laminectomy, and Spinal Fusion. Dr. Theodore is currently accepting new patients.

Dr. Ali Bydon is a renowned neurosurgeon and director of the Division of Spine Surgery and the Neurosurgical Spine Center at the Johns Hopkins University School of Medicine. As the endowed Ziya Gokaslan Professor of Neurosurgery, he is dedicated to advancing the field through innovative clinical practices and extensive research. Additionally, Dr. Bydon serves as the vice chair for strategic planning within the Department of Neurosurgery. Dr. Bydon’s clinical practice is centered on degenerative disorders of the spine, spinal tumors, spinal trauma and complex spinal reconstruction. He is an esteemed member of the American Association of Neurological Surgeons and the Congress of Neurological Surgeons. Dr. Bydon earned his medical degree from the University of Michigan School of Medicine in 1999 and completed his residency in neurological surgery at Henry Ford Hospital in Detroit, where he graduated with distinction in 2006. He further honed his skillset by completing fellowships in minimally invasive spine surgery and the surgical treatment of peripheral nerves, followed by a one-year instructorship in spinal oncology and complex reconstructive spinal surgery at Johns Hopkins in 2007. His research focuses on spinal biomechanics and surgical outcomes. He has co-authored over 265 peer-reviewed manuscripts and numerous book chapters. Dr. Bydon has made significant contributions to the understanding of optimal surgical management for conditions such as spinal synovial cysts, cervical myelopathy, lumbar spondylolisthesis, ossified posterior longitudinal ligament, cervical degenerative disorders, cervical myelopathy, thoracic myelopathy and metastatic diseases to the spine, among others. Dr. Bydon has presented at more than 200 national and international scientific meetings, underscoring his commitment to advancing knowledge in the field. An educator who has trained over 75 practicing neurosurgeons, Dr. Bydon has received prestigious accolades, including the Richard Otenasak Faculty Teaching Award and the Chairman’s Neurosurgical Teacher of the Year Award. His leadership roles have included serving on the residency review committee and the patient access committee at Johns Hopkins, as well as a yearlong term as the neurosurgical representative on the Johns Hopkins Faculty Senate. He has also served as a medical director with Johns Hopkins Medicine International, overseeing clinical and educational activities at renowned institutions in Lebanon and Brazil. Dr. Bydon has performed more than 5,000 surgeries. His commitment to excellence in patient care, education and research makes him a leading authority in spine surgery, dedicated to providing transformative care to patients seeking relief and recovery. Dr. Bydon is rated as an Advanced provider by MediFind in the treatment of Spinal Tumor. His top areas of expertise are Spondylolisthesis, Spinal Stenosis, Invertebral Disc Disease, Laminectomy, and Spinal Fusion.

Dr. Gary Gallia's specialty is endoscopic endonasal surgical approaches to skull base pathologies with a focus on neurosurgical oncology. He utilizes the latest techniques in preoperative imaging, computer-guided surgical navigation, intraoperative monitoring, and minimally invasive and Neuroendoscopy approaches in the management of patients with benign and malignant brain tumors, metastatic tumors to the brain, skull base neoplasms, and pituitary tumors. He is the director of the Neurosurgery Skull Base Center and surgical director of the Johns Hopkins Pituitary Center. Dr. Gary Gallia graduated summa cum laude from the Gibbons Scholar MD/PhD program at Jefferson Medical College and Thomas Jefferson University. He completed his general surgery internship at The Johns Hopkins Hospital where he was awarded surgical intern of the year. He then completed his neurological surgery residency and a postdoctoral fellowship in neuro-oncology at The Johns Hopkins Hospital. Following residency, he completed a minimally invasive and endoscopic neurosurgery fellowship with Dr. Charles Teo at the Prince of Wales Private Hospital and Sydney Children's Hospital in Sydney, Australia. Dr. Gallia is rated as an Experienced provider by MediFind in the treatment of Spinal Tumor. His top areas of expertise are Olfactory Neuroblastoma, Chordoma, Pituitary Tumor, Endoscopic Transnasal Transsphenoidal Surgery, and Awake Craniotomy.

Dr. Bhargava developed an interest in immunology early in medical school at the Christian Medical College in Vellore, India. He then completed his neurology training at the Southern Illinois University School of Medicine and while there began research in the field of multiple sclerosis (MS). Following his neurology training he completed a 3-year fellowship at the Johns Hopkins University in neuroimmunology and neurological infections focusing on MS clinical care and research. His fellowship training was supported by a Sylvia Lawry physician fellowship award from the National MS Society. His main research interests include studying the role of inflammation in the meninges in progression of MS disease. He is currently involved in a trial testing the utility of injecting a drug called rituximab into the spinal fluid in patients with progressive MS. He is also developing an animal model of the process of meningeal inflammation to test other potential treatments. This work is supported by awards from the National MS Society, Race to Erase MS and the American Academy of Neurology. He is also actively involved in studying the role of measuring lipids and small molecule metabolites in serum and plasma to help identify new biomarkers for improved diagnosis and prognosis of the disease. These methods could also help in better tracking the effects of various interventions and in personalizing the treatment of patients with MS. Dr. Bhargava is rated as an Experienced provider by MediFind in the treatment of Spinal Tumor. His top areas of expertise are Multiple Sclerosis (MS), Relapsing Multiple Sclerosis (RMS), Transverse Myelitis, and CACH Syndrome.

Sahaja Acharya is the Director of Pediatric Radiation Oncology within the Department of Radiation Oncology and Molecular Radiation Sciences. She specializes in pediatric brain tumors, pediatric sarcomas, and adult sarcomas. She is also the Associate Director for the Radiation Oncology Residency Program. She leads the Pediatric Radiation Oncology program at the Johns Hopkins Hospital and treats patients at both Johns Hopkins Hospital and Sibley Memorial Hospital. She has extensive expertise in proton therapy, SBRT, pediatric malignancies, and adult sarcoma. She is the Principal Investigator on external grants from ASCO Conquer Cancer, the Department of Defense, and the Carson Leslie Foundation. She is also the Principal Investigator of phase II pediatric brain tumor clinical trials. She has been invited to participate in multiple national and international guideline committees and regularly lectures on pediatric malignancies and proton therapy. Dr. Acharya received her Bachelor's in Chemistry and Political Science from Stanford University and her medical degree from Saint Louis University. She completed radiation oncology residency at Washington University in St. Louis. Dr. Acharya is rated as an Experienced provider by MediFind in the treatment of Spinal Tumor. Her top areas of expertise are Brain Tumor, Gliomatosis Cerebri, Glioma, and Posterior Fossa Tumor.

Henry Brem is a Neurosurgery provider in Baltimore, Maryland. Dr. Brem is rated as an Experienced provider by MediFind in the treatment of Spinal Tumor. His top areas of expertise are Gliosarcoma, Glioma, Brain Tumor, Endoscopic Transnasal Transsphenoidal Surgery, and Osteotomy.

Dr. Kristin Redmond specializes in the treatment of brain tumors and leads the spinal radiosurgery program. She received her undergraduate degree from Princeton University where she graduated magna cum laude with a focus in neuro-psychology. She attended medical school and obtained a Masters in Public Health in health systems management at Tulane University where she was elected to the Alpha Omega Alpha Honor Medical Society as well as the Gold Humanism in Medicine Honor Society. Dr. Redmonds research interest focuses on the development of novel radiation techniques and therapeutic agents to treat brain and spine tumors in order to increase tumor control and overall survival. In addition, she is working to develop innovative approaches to try to limit long term toxicities and minimize neuro-cognitive dysfunction following treatment for tumors of the central nervous system. Dr. Redmond believes in a holistic approach to medicine and feels that the social and psychological components of patient care are equally important to traditional therapies. She works closely with a team of specialists to support patients and families during their cancer journey. Make A Gift. Dr. Redmond is rated as an Experienced provider by MediFind in the treatment of Spinal Tumor. Her top areas of expertise are Chordoma, Brain Tumor, Astrocytoma, and Metastatic Brain Tumor.

Dr. Jon Weingart focuses on the surgical treatment of brain tumors including benign and malignant tumors. Dr. Weingart also specializes in spinal disorders, such as cervical and lumbar disc disease, as well as other congenital and developmental abnormalities such as tethered spinal cord, spina bifida and chiari malformation. Dr. Weingart is rated as an Experienced provider by MediFind in the treatment of Spinal Tumor. His top areas of expertise are Glioblastoma, Astrocytoma, Glioma, Awake Craniotomy, and Osteotomy.

Dr. Eric Jackson specializes in the evaluation and treatment of patients with a broad range of neurosurgical disorders, including congenital malformations of the brain and spine, hydrocephalus (including endoscopic treatment), chiari malformation, craniosynostosis, spinal dysraphism/tethered cord, brain and spinal cord tumors, and traumatic brain injuries. He is the Principal Investigator for several multi-institution research studies, including: Hydrocephalus Clinical Research Network: currently investigating endoscopic surgery vs shunting for the treatment of hydrocephalus in infants in a $10M randomized trial funded by the NIH Park Reeves Syringomyelia Research Consortium Advancing the treatment for pediatric craniopharyngioma, identifying biological targets for molecular therapy A multi-institutional trial investigating a non-invasive eye tracking device for assessing increased intracranial pressure. Dr. Jackson is rated as an Experienced provider by MediFind in the treatment of Spinal Tumor. His top areas of expertise are Hydrocephalus, Chiari Malformation, Chiari Malformation Type 2, Posterior Fossa Decompression, and Endoscopy.

Dr. Caplan specializes in the treatment of cerebrovascular disorders of the brain, head, neck and spine, such as aneurysms, arteriovenous malformations, arteriovenous fistulas, moyamoya disease, carotid artery stenosis and stroke. He is dual fellowship trained in both open cerebrovascular neurosurgery and endovascular neurosurgery, allowing him to offer patients the full spectrum of the latest surgical and endovascular techniques in treating these diseases. Dr. Caplan also focuses on treating acoustic neuromas and other tumors of the skull base, including meningiomas. Dr. Caplan graduated with honors from the Johns Hopkins University with a degree in neuroscience, where he spent time in the Hunterian Neurological Surgery Research Laboratory. He then earned his medical degree from Harvard Medical School. He completed his neurosurgery residency at Johns Hopkins, along with fellowships in cerebrovascular neurosurgery and endovascular neurosurgery, also at Johns Hopkins. He then completed an additional fellowship in endovascular neurosurgery at the University of Miami before returning to join the Johns Hopkins faculty. Dr. Caplan is rated as an Experienced provider by MediFind in the treatment of Spinal Tumor. His top areas of expertise are Brain Aneurysm, Arteriovenous Malformation, Cerebral Arteriovenous Malformation, Thrombectomy, and Carotid Artery Surgery.

Dr. Jaishri Blakeley is the Marjorie Bloomberg Tiven Professor of Neurofibromatosis in Neurology, Oncology, and Neurosurgery at Johns Hopkins School of Medicine, director of the Johns Hopkins Comprehensive Neurofibromatosis Center and director of the Neurofibromatosis Therapeutic Acceleration Program (NTAP). She is an active clinician-scientist specializing in the care of people with NF1, NF2, LZTR1, SMARC1 schwannomatoses, and primary brain tumors. Her research expertise in the development of clinical trials for nervous system tumors and specifically, early clinical-translational studies including tumor pharmacokinetic and pharmacodynamic investigations, imaging biomarkers for rare nervous system tumors, and incorporation of patient-focused, functional endpoints into efficacy studies. She has been the national or international leader of 7 clinical trials focused on therapies for glioblastoma, NF1 and NF2. In 2012 she cofounded the NTAP to dramatically shift the landscape of NF1 via necessary, efficient, and expert discovery, translational and clinical research. NTAP focuses on therapeutics, fosters collaboration, facilitates open and timely sharing of results, and streamlines the research process to accelerate therapies for plexiform and cutaneous neurofibromas. Through NTAP, Dr. Blakeley has supported and collaborated with more than 80 laboratories and research teams across the globe enabling meaningful therapeutic development for NF1-associated neoplasms and supporting the development of an exceptional community of clinician scientists focused on NF1 via the Francis S. Collins Scholars Program in Neurofibromatosis Clinical and Translational Research. Her research and programmatic efforts are all in the service of improving outcomes for the patients with NF1, NF2, schwannomatosis, and primary brain cancer for whom she is honored to provide care. Dr. Blakeley is rated as an Experienced provider by MediFind in the treatment of Spinal Tumor. Her top areas of expertise are Neurofibromatosis, Schwannomatosis, Neurofibromatosis Type 2 (NF2), Neurofibromatosis Type 1 (NF1), and Laminectomy.

Dr. Allan Belzberg is a neurosurgeon specializing in surgery of the peripheral nervous system. As Director of Peripheral Nerve Surgery at Johns Hopkins in Baltimore, he treats tumors including schwannoma, neurofibroma and nerve sheath tumor. Dr. Belzberg performs surgical repair of nerve damage caused by trauma as well as neurosurgery on carpal tunnel, peroneal nerve and other peripheral nerve conditions. Dr. Belzberg also directs the Brachial Plexus and Peripheral Nerve Clinic at the Kennedy Krieger Institute and co-directs the Neurosurgery Pain Research Institute at Johns Hopkins Hospital. Dr. Belzberg currently sees patients at the Johns Hopkins Outpatient Center located in Baltimore on Wednesdays and the Green Spring Station location on Fridays. Dr. Belzberg is rated as an Experienced provider by MediFind in the treatment of Spinal Tumor. His top areas of expertise are Schwannomatosis, Neurofibromatosis, Thoracic Outlet Syndrome, Osteotomy, and Rhizotomy.

Dr. Majid Khan is a Radiologist and Director, Non-Vascular Spine Intervention at Johns Hopkins University hospitals. Dr. Khan graduated from University of Kashmir, India in 1993. He completed his residency in radiology at the Nassau University Medical Center at Stony Brooks University and then completed his fellowship in Neuroradiology at Johns Hopkins University. Dr. Majid is deeply invested in both diagnostic Neuroradiology with particular emphasis on advanced head & neck and spine tumor imaging. His prime interest is doing spine tumor ablations primarily using microwave ablation devices and has performed the most number of such cases in the United States. He has significant expertise in spine cement augmentation procedures like kyphoplasty and vertebroplasty for treatment of compression fractures due to osteoporosis, multiple myeloma and/or other tumor-associated pathological fractures, sacroplasty for the treatment of fractures of the sacrum, epidural steroid injections, facet and transforaminal nerve blocks. He has treated a considerable number of patients with Tarlov and synovial cysts. Dr. Khan is a core member of Johns Hopkins Headaches and CSF Leak Program doing both targeted and non-targeted blood and fibrin glue patches. In addition, Dr. Khan has performed numerous imaging-guided head and neck biopsies with expertise in deep trans-facial biopsies. Dr. Majid has contributed to numerous publications and book chapters and has given regional, national and international talks, as well as presented research at many national meetings. He is a member of the American Society of Neuroradiology, American College of Radiology, American Society of Spine Radiology, North American Spine Society, Radiologic Society of North America, European Society of Radiology. Dr. Khan is rated as an Experienced provider by MediFind in the treatment of Spinal Tumor. His top areas of expertise are Cerebrospinal Fluid Leak, Meningocele, Tarlov Cysts, Vertebroplasty, and Bone Graft.

Dr. Haris Sair is Professor in the Johns Hopkins Medicine Department of Radiology and Radiological Science, and the Director of the Division of Neuroradiology. His areas of clinical expertise include functional Magnetic Resonance Imaging (fMRI) of the brain. He also has a faculty appointment in the Malone Center for Engineering in Healthcare at The Whiting School of Engineering, Johns Hopkins University, investigating the use of machine learning and artificial intelligence in imaging. He is a founding director of the Radiology Artificial Intelligence Lab (RAIL). He previously served as the President of the American Society of Functional Neuroradiology. Dr. Sair earned his M.D. from Duke University School of Medicine. He completed his Radiology residency at Temple University Medical Center, and fellowship in Neuroradiology at Massachusetts General Hospital in Boston, MA. Dr. Sair is rated as an Experienced provider by MediFind in the treatment of Spinal Tumor. His top areas of expertise are Hydrocephalus, Normal Pressure Hydrocephalus, Traumatic Brain Injury, Cerebrospinal Fluid Leak, and Microvascular Decompression.

Alessandro Olivi is a Neurosurgery provider in Baltimore, Maryland. Dr. Olivi is rated as an Advanced provider by MediFind in the treatment of Spinal Tumor. His top areas of expertise are Glioblastoma, Astrocytoma, Glioma, Microvascular Decompression, and Craniectomy.

Jordina Rincon-Torroella is a fellowship-trained neurosurgeon specializing in the surgical treatment of benign and malignant tumors of the brain and skull base, such as meningiomas, gliomas, pituitary tumors and metastatic brain tumors, to name a few. Dr. Rincon-Torroella earned her medical degree from the University of Barcelona medical school. She completed a postdoctoral fellowship in neurosurgical oncology at Johns Hopkins University, where she remained for residency training in neurosurgery. She completed an additional postdoctoral fellowship in cancer research and drug development at Johns Hopkins in the Ludwig Center under the mentorship of neurosurgeon Chetan Bettegowda and molecular biologist and geneticist Bert Vogelstein. Active in clinical research since 2010, Dr. Rincon-Torroella has published numerous research papers. She is also a peer reviewer for several journals and has edited two books, most recently The Neurosurgical Consult Book. Dr. Rincon-Torroella is fluent in Catalan, English and Spanish. Dr. Torroella is rated as an Experienced provider by MediFind in the treatment of Spinal Tumor. Her top areas of expertise are Subependymoma, Ependymoma, Brain Tumor, Laminectomy, and Craniectomy.

Judy Huang is a Neurosurgery provider in Baltimore, Maryland. Dr. Huang is rated as an Advanced provider by MediFind in the treatment of Spinal Tumor. Her top areas of expertise are Trigeminal Neuralgia, Arteriovenous Malformation, Subdural Hematoma, Rhizotomy, and Microvascular Decompression. Dr. Huang is currently accepting new patients.

Dr. Debraj “Raj” Mukherjee’s clinical focus is the treatment of patients with primary and metastatic brain lesions. His clinical work and research emphasize the development of individual treatment plans that optimize survival and quality of life in all patients. After receiving his medical degree from Dartmouth Medical School, Dr. Mukherjee was recruited to Johns Hopkins, where he studied epidemiology, biostatistics and clinical design at the Johns Hopkins Bloomberg School of Public Health and served as Director of the Neuro-Oncology Surgical Outcomes Laboratory in the Department of Neurosurgery. Dr. Mukherjee completed neurosurgery residency at Cedars-Sinai Medical Center, where he was named a Robert Wood Johnson Foundation Health & Society Scholar. He completed an open and endoscopic skull base fellowship with the Center for Skull Base Surgery at University of Pittsburgh Medical Center, where he was a Copeland Scholar. Throughout his career, Dr. Mukherjee has led patient-centered research pursuits in neuro-oncology including development of a national registry for patients with brain tumors, creation of disease-specific quality of life instruments for patients with skull base tumors, and development of innovative clinical trials in neuro-oncology. He leads the Meningioma, Brain Metastasis, and Neurosurgical Oncology centers at Johns Hopkins Medicine, and he serves as Assistant Residency Program Director for one of the largest neurosurgical training programs in the country. His work has been supported by the American Medical Association, Glioblastoma Foundation, National Institute on Aging, and National Cancer Institute. Dr. Mukherjee can be contacted at drraj@jhmi.edu. Dr. Mukherjee is rated as an Experienced provider by MediFind in the treatment of Spinal Tumor. His top areas of expertise are Meningioma, Pituitary Tumor, Brain Tumor, Awake Craniotomy, and Laminectomy.